Drugs / Urocortin 2
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable2 trials | ||||||
| — | NCT01599728 | May → Jul 2012 | heart failure | University of Edinburgh | Completed | No outcome recorded |
| — | NCT01296607 | Feb → Jun 2011 | heart failure | University of Edinburgh | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT01096693 Comparator | Aug 2010 → Aug 2012 | heart disorder, vascular disorder | University of Edinburgh | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Urocortin 2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01096693 ↗ |
| Modality | Protein / enzyme biologic | “Urocortins are proteins that appear to increase blood flow and heart pumping activity.” NCT01096693 ↗ |
| Route | Other | “intra arterial Urocortin 2” NCT01096693 ↗ |